The Latest Breaking News from Moderna

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The speed of which the Covid jab was developed has "unspooled" medical advancements

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Experts hope new vaccines will be ready by end of decade

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

It was based on 860,000 patients across the world. The post Being vaccinated halves risk of long COVID: study appeared first on Talker.

Tuberculosis surrendered the title of the world’s deadliest infectious disease after COVID-19 struck, but it reclaimed that terrible distinction last year. As with COVID, a new vaccine could go a long way to sharply curtailing the disease, which killed about 1.4 million people a year before the pandemic and increased…